Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Neoplasms × Histological Techniques × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Salivary Gland Neoplasms 1 Precancerous Conditions 1 Disease 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 360 Trastuzumab 348 Paclitaxel 304 Docetaxel 271 Capecitabine 221 Letrozole 220 Carboplatin 185 Doxorubicin 181 Tamoxifen 156 Radiotherapy 153 Epirubicin 145 Fulvestrant 142 Anastrozole 138 Surveys and Questionnaires 131 Exercise 127 Vinorelbine 110 pertuzumab 109 Blood Specimen Collection 108 exemestane 105 palbociclib 104 Bevacizumab 104 pembrolizumab 98 Magnetic Resonance Spectroscopy 97 Albumin-Bound Paclitaxel 87 Gemcitabine 84 Drug Therapy 82 Lapatinib 78 130-nm albumin-bound paclitaxel 72 Neoadjuvant Therapy 70 Cisplatin 69

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01668914 2018-04-05

IMSLNB-CANP

Shandong Cancer Hospital and Institute

Phase 3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡